First Affiliated Hospital of Guangxi Traditional Chinese Medicine University, Nanning 530023, China.
J Ethnopharmacol. 2012 Oct 11;143(3):889-95. doi: 10.1016/j.jep.2012.08.018. Epub 2012 Aug 28.
Methyl helicterate is a triterpenoid isolated from Helicteres angustifolia (Sterculiaceae), one of the valuable traditional Chinese herbs. Antifibrotic activities of H. angustifolia have been extensively proved.
The purpose of this study was to investigate the effect of methyl helicterate (MH) on liver fibrosis in rats induced by carbon tetrachloride (CCl(4)) and to explore its underlying mechanism.
Hepatic fibrosis was induced in male Sprague-Dawley (SD) rats by intragastric administration with 2 ml/kg CCl(4) (mixed 1:1 in peanut oil) twice a week for 12 weeks. To evaluate the effect of MH (16.72, 33.45, 66.90 mg/kg) on hepatic fibrosis, liver function, histological study and hepatic fibrosis evaluation were performed. Liver function was assessed by determining the serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (Alb) and total protein (TP). The biomarkers such as hydroxyproline (Hyp), hyaluronic acid (HA), type III precollagen (PCIII) and laminin (LN) were examined for the evaluation of hepatic fibrosis. The underlying mechanism was investigated by measuring oxidative stress level and detecting the expression of TGF-β1 mRNA and Smad3 protein.
MH (33.45, 66.90 mg/kg) treatment significantly inhibited the loss of body weight and the increase of liver index in rats induced by CCl(4). MH also improved the liver function as indicated by decreasing serum enzymatic activities of ALT, AST, TP and Alb (P<0.05). Histological results indicated that MH alleviated liver damage and reduced the formation of fibrous septa. Moreover, MH significantly decreased liver Hyp, HA, LN and PCIII (P<0.05). Research on mechanism showed that MH could markedly reduce liver malondialdehyde (MDA) concentration, increase activities of liver superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and inhibit the expression of TGF-β1 mRNA and Smad3 protein (P<0.05).
Our findings indicated that MH can inhibit CCl(4)-induced hepatic fibrosis, which may be ascribed to its radical scavenging action, antioxidant activity, and modulation of TGF-β-Smad3 signaling pathway.
ETHNOPHARMACOLOGICAL 相关性:甲基 Helicterate 是一种三萜类化合物,从 Helicteres angustifolia(梧桐科)中分离出来,这是一种有价值的传统中药。已经广泛证明了 H. angustifolia 的抗纤维化活性。
本研究旨在探讨甲基 Helicterate(MH)对四氯化碳(CCl4)诱导的大鼠肝纤维化的影响,并探讨其潜在机制。
雄性 Sprague-Dawley(SD)大鼠通过胃内给予 2ml/kg CCl4(在花生油中混合 1:1),每周两次,共 12 周,诱导肝纤维化。为了评估 MH(16.72、33.45、66.90mg/kg)对肝纤维化的影响,进行了肝功能、组织学研究和肝纤维化评估。通过测定血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、白蛋白(Alb)和总蛋白(TP)来评估肝功能。羟脯氨酸(Hyp)、透明质酸(HA)、III 型前胶原(PCIII)和层粘连蛋白(LN)等生物标志物用于评估肝纤维化。通过测量氧化应激水平和检测 TGF-β1mRNA 和 Smad3 蛋白的表达来研究潜在机制。
MH(33.45、66.90mg/kg)治疗显著抑制了 CCl4 诱导的大鼠体重减轻和肝指数增加。MH 还通过降低血清酶 ALT、AST、TP 和 Alb 的活性来改善肝功能(P<0.05)。组织学结果表明,MH 减轻了肝损伤并减少了纤维隔的形成。此外,MH 显著降低了肝 Hyp、HA、LN 和 PCIII(P<0.05)。机制研究表明,MH 可显著降低肝丙二醛(MDA)浓度,增加肝超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)的活性,并抑制 TGF-β1mRNA 和 Smad3 蛋白的表达(P<0.05)。
我们的研究结果表明,MH 可以抑制 CCl4 诱导的肝纤维化,这可能归因于其清除自由基的作用、抗氧化活性以及调节 TGF-β-Smad3 信号通路。